TLDR

• AI-native quality management systems sit across data, models, and governance to provide continuous validation, monitoring, and documentation for AI used in pharma and life sciences workflows.​
• Their main value is shifting quality from static, document-heavy controls to real-time performance dashboards, drift detection, and automated handling of deviations, CAPAs, and SOP updates as models evolve.​
• These systems are becoming mandatory for high-risk AI under the EU AI Act and expected under FDA GMLP and ISO/IEC 42001, making lifecycle oversight and post-market monitoring core compliance requirements.
• Evaluation should focus on integration with existing QMS, SaMD and ML pipelines, support for AI management system concepts, and the ability to maintain traceable audit trails and live compliance evidence.
• Organisations that delay AI-native QMS adoption risk regulatory lag, unmanaged model drift, and loss of trust, while early adopters can scale AI more safely without quality becoming a bottleneck.

AI is transforming healthcare and life sciences fast, but there’s one piece of the puzzle that hasn’t kept up: the quality management system. High-risk AI in the EU will actually be required to sit inside a documented quality management system under the EU AI Act, which explicitly calls this out for providers of high-risk AI systems [1,2].

For years, quality systems have been built for predictable, document-heavy processes. They were never designed for machine learning models that adapt, learn, and evolve on their own. If pharma wants to use AI safely and at scale, it’s time to rebuild the QMS from the ground up. We need an AI-native quality management system, one that can keep pace with intelligent, ever-changing algorithms.

What Is a Quality Management System in the AI Era?

Let’s start with the basics: what is a quality management system today? Traditionally, it’s the framework that keeps products, data, and processes compliant, with written policies, procedures, instructions, and defined responsibilities [1]. It’s your SOPs, validation reports, and documentation trails. The backbone of regulated operations.

But here’s the catch: AI doesn’t fit neatly into that structure. Models are constantly retrained, data changes every day, and risk has to be managed across the full lifecycle, not just at launch [3,6]. Biases can creep in unexpectedly, and that old “validate it once and you’re done” mindset just doesn’t work anymore. We need to shift from static validation to continuous validation and monitoring. Instead of proving something worked at one point in time, we need systems that show it still works. Right now. AI doesn’t stop learning. Neither should your QMS.

From Paper Compliance to Continuous Validation

In the old world, validation meant a single milestone. Test it, document it, tick the compliance box (sure, there was also risk-based, change-controlled and periodic revalidation). In the AI world, that approach falls apart. Models evolve, data moves, and regulators are starting to expect lifecycle oversight rather than one-off approvals for AI-enabled software as a medical device (SaMD) [5,6]. What was “validated” yesterday might be non-compliant tomorrow.

An AI-era quality management system needs to run constant checks in the background, automatically. Think continuous validation instead of periodic review. Here’s what that looks like in practice:

• Real-time model performance dashboards tied directly to compliance metrics.

• Smart alerts when drift or anomalies occur so risk controls can be triggered early.

• Live data quality monitoring and automated testing across the AI lifecycle [6].

• Seamless links to your ML pipeline or cloud platform so every change is traceable.

It’s the difference between checking your AI once a year and knowing what it’s doing every minute.

Quality Management System Software: From Static to Smart

The next wave of quality management system software doesn’t just digitise files, it connects the dots. These platforms use AI to automate classification, analyse risk, and spot patterns humans would miss, aligning with emerging AI management system (AIMS) concepts such as ISO/IEC 42001 [7,8]. They manage change controls, deviations, and CAPAs in real time and adapt as your models evolve.

For pharma and life sciences teams, that means:

• Deviations automatically classified and escalated by machine learning.

• Automated prompts to update SOPs based on system behaviour and identified risks.

• Built-in model lifecycle management, from development to retraining—consistent with an “AI management system” approach [7,10].

• Alignment with the latest AI regulations, like the EU AI Act and FDA’s Good Machine Learning Practice (GMLP) principles [1,6].

In short, your quality system stops being a static archive. It becomes your operational intelligence layer. Always watching, always learning.

New Standards for AI in Life Sciences

Regulators know this shift is happening, and they’re responding. We’re seeing new frameworks emerge across the board:

• The EU AI Act: Introduces a risk-based classification for AI and requires a documented quality management system, risk management, data governance, transparency, and post-market monitoring for high-risk AI [1,4,9].

• The FDA’s GMLP: Guidance and AI/ML action plans emphasize lifecycle oversight, transparency, real-world performance monitoring, and continuous model control for AI-enabled software as a medical device [5,6].

• ISO/IEC 42001: This international standard sets the groundwork for AI management systems, including continuous improvement, risk management, and governance for organizations that develop or use AI [7,8].

These standards have one thing in common: compliance isn’t a one-time event anymore. To keep up, pharma needs an AI-native quality management system that tracks AI’s evolution and keeps governance in sync with every model update.

Moving Beyond Manual SOP Culture

Let’s be honest. Even “digital” quality management still relies on manual work. PDFs, email approvals, and checklists in Excel can’t handle AI’s speed. When models change in hours, manual processes slow everything down and make it harder to prove continuous control.

A digital-first QMS flips the script:

• It uses AI to detect and classify non-conformances automatically across large volumes of data.

• It triggers CAPAs based on data, not calendars, making risk management more responsive.

• It generates live compliance dashboards regulators and auditors can review instead of static reports [9,10].

Replacing SOP paperwork with digital QMS platforms doesn’t mean losing control. It means finally keeping up, without burning out your team or risking compliance.

Making Quality a Living Intelligence Layer

The modern quality management system should act like a living, learning brain embedded in your organisation. An AI management system aligned with ISO/IEC 42001 concepts focuses on continual improvement, risk assessment, and impact monitoring so the organisation can steer AI responsibly [7,8]. Imagine a QMS that spots patterns across hundreds of data streams, flags risks before you notice them, and recommends fixes automatically.

Quality becomes proactive, not reactive.

Why This Matters Now

Organisations that don’t adapt will face real challenges:

1. Regulatory lag: You can’t prove compliance for a model that’s always changing if your systems assume one-time validation [3].

2. Operational risk: Model drift can lead to safety or ethical failures if you’re not monitoring real-world performance [6,10].

3. Erosion of trust: Regulators and partners will expect visible AI governance, including clear documentation, logs, and monitoring [1,2].

On the flip side, moving to AI-native quality management system software means you’ll stay compliant continuously, scale AI innovation faster because quality isn’t a bottleneck, and build trust with transparency baked into every workflow.

Building the AI-Native QMS

To start, you need three layers working in harmony:

• Data layer: Ongoing data quality tracking and lineage visibility so AI inputs stay reliable and traceable.

• Model layer: Version control and lifecycle management for every model, aligned with AI/ML regulatory expectations [6].

• Governance layer: Automated policy checks, explainability, documentation, and audit trails consistent with frameworks like the EU AI Act and ISO/IEC 42001 [1,7].

Together, these layers form the backbone of an AI-native quality management system—one that learns as fast as the technology it governs.

The Takeaway

Quality management systems built for paper trails can’t handle predictive models. They weren’t designed for continuous change, but that’s exactly what AI demands. To move forward, pharma needs to see quality not as a checkbox, but as a dynamic discipline that learns, adapts, and scales. The future of compliance isn’t static. It’s smart.

Advancing with the future of quality management systems? Discover our curated list to see how industry leaders are accelerating timelines, implementing AI solutions in healthcare and gaining a competitive edge. Follow us for more actionable AI insights shaping the future of life sciences and AI in healthcare.

References 

1. European Commission. Artificial Intelligence Act – Articles 16–17: Obligations and Quality Management Systems for High-Risk AI Systems. [July] 2024. (Note: While proposed in 2023, the final text was adopted in early 2024 and entered into force August 2024).

2. European Commission. Artificial Intelligence – Questions & Answers (Risk-Based Framework and High-Risk AI Requirements). [December] 2021.

3. Covington & Burling LLP. EU AI Act: Key Considerations for the Life Sciences Sector. Journal of Robotics, Artificial Intelligence & Law. [January] 2025.

4. IQVIA. EU AI Act – Here’s How This Will Affect Your Organisation. [May] 2024.

5. NAMSA. FDA’s Regulation of AI/ML SaMD. [January] 2024.

6. U.S. Food and Drug Administration (FDA). Artificial Intelligence in Software as a Medical Device (AI/ML SaMD) – Action Plan and GMLP Principles. [October] 2021 (Updated [April] 2023).

7. International Organization for Standardization (ISO) / International Electrotechnical Commission (IEC). ISO/IEC 42001:2023 – Information Technology – Artificial Intelligence – Management System. [December] 2023.

8. ISMS.online. Understanding ISO 42001 and Demonstrating Compliance. [January] 2025.

9. PSC Software. EU AI Act: Impact on Life Sciences and Medtech. [February] 2025.

10. Intuition Labs. The EU AI Act & Pharma: Compliance Guide + Flowchart. [March] 2025.